Dougie22
Well-Known Member
I have been trying to understand how my diet and exercise regime, which is generally if slowly reducing weight, blood pressure and, crucially IMHO, HbA1c is having a negative effect on my total cholesterol level. It seems to be counteer intuitive as losing weight and eating healthily should, in theory, also reduce cholesterol at least a little, not increase it.
I was reading the Sign 116 (Scottish health service recommendations to doctors) for another reason and came across this little gem:
"In patients with type 2 diabetes, a systematic review of short term supplementation with omega-3 polyunsaturated fatty acid (PUFA) showed a reduction in triglycerides (TG) but a rise in low
density lipoprotein (LDL) cholesterol."
Now, this struck a chord with me because, on the recommendation of the dietician, I have been taking daily 1000mg Omega 3 capsules for six months or so.
When I read the full article though, it suggests that total cholesterol readings won't be increased (this is what happened in my case) so the whole thing may be a red herring.
The full study can be found at:
http://summaries.cochrane.org/CD003...fatty-acids-pufa-for-type-2-diabetes-mellitus
The extract reads in part:
Main results:
Twenty three randomised controlled trials (1075 participants) were included with a mean treatment duration of 8.9 weeks. The mean dose of omega-3 PUFA used in the trials was 3.5 g/d. No trials with vascular events or mortality endpoints were identified. Among those taking omega-3 PUFA triglyceride levels were significantly lowered by 0.45 mmol/L (95% confidence interval (CI) -0.58 to -0.32, P < 0.00001) and VLDL cholesterol lowered by -0.07 mmol/L (95% CI -0.13 to 0.00, P = 0.04). LDL cholesterol levels were raised by 0.11 mmol/L (95% CI 0.00 to 0.22, P = 0.05). No significant change in or total or HDL cholesterol, HbA1c, fasting glucose, fasting insulin or body weight was observed. The increase in VLDL remained significant only in trials of longer duration and in hypertriglyceridemic patients. The elevation in LDL cholesterol was non-significant in subgroup analyses. No adverse effects of the intervention were reported.
Authors' conclusions:
Omega-3 PUFA supplementation in type 2 diabetes lowers triglycerides and VLDL cholesterol, but may raise LDL cholesterol (although results were non-significant in subgroups) and has no statistically significant effect on glycemic control or fasting insulin. Trials with vascular events or mortality defined endpoints are needed.
This record should be cited as:
Hartweg J, Perera R, Montori VM, Dinneen SF, Neil AHAWN, Farmer AJ. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD003205. DOI: 10.1002/14651858.CD003205.pub2
Anyone out there have any insights on this matter?
I was reading the Sign 116 (Scottish health service recommendations to doctors) for another reason and came across this little gem:
"In patients with type 2 diabetes, a systematic review of short term supplementation with omega-3 polyunsaturated fatty acid (PUFA) showed a reduction in triglycerides (TG) but a rise in low
density lipoprotein (LDL) cholesterol."
Now, this struck a chord with me because, on the recommendation of the dietician, I have been taking daily 1000mg Omega 3 capsules for six months or so.
When I read the full article though, it suggests that total cholesterol readings won't be increased (this is what happened in my case) so the whole thing may be a red herring.
The full study can be found at:
http://summaries.cochrane.org/CD003...fatty-acids-pufa-for-type-2-diabetes-mellitus
The extract reads in part:
Main results:
Twenty three randomised controlled trials (1075 participants) were included with a mean treatment duration of 8.9 weeks. The mean dose of omega-3 PUFA used in the trials was 3.5 g/d. No trials with vascular events or mortality endpoints were identified. Among those taking omega-3 PUFA triglyceride levels were significantly lowered by 0.45 mmol/L (95% confidence interval (CI) -0.58 to -0.32, P < 0.00001) and VLDL cholesterol lowered by -0.07 mmol/L (95% CI -0.13 to 0.00, P = 0.04). LDL cholesterol levels were raised by 0.11 mmol/L (95% CI 0.00 to 0.22, P = 0.05). No significant change in or total or HDL cholesterol, HbA1c, fasting glucose, fasting insulin or body weight was observed. The increase in VLDL remained significant only in trials of longer duration and in hypertriglyceridemic patients. The elevation in LDL cholesterol was non-significant in subgroup analyses. No adverse effects of the intervention were reported.
Authors' conclusions:
Omega-3 PUFA supplementation in type 2 diabetes lowers triglycerides and VLDL cholesterol, but may raise LDL cholesterol (although results were non-significant in subgroups) and has no statistically significant effect on glycemic control or fasting insulin. Trials with vascular events or mortality defined endpoints are needed.
This record should be cited as:
Hartweg J, Perera R, Montori VM, Dinneen SF, Neil AHAWN, Farmer AJ. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD003205. DOI: 10.1002/14651858.CD003205.pub2
Anyone out there have any insights on this matter?